Table 1: Patient population characteristics (n=25)
Age (years), mean±s.d 58.5±14.1
Male, n (%) 23 (92)
Hypertension, n (%) 21 (84)
BMI, mean±s.d 27.6±5.0
Diabetes, n (%) Requiring insulin treatment, n (%) 21 (84) 20 (80)
CKD, n (%) Requiring hemodialysis, n (%) 18 (72) 12 (48)
HF, n (%) 20 (80)
Arrhythmic substrate Ischemic cardiomyopathy, n (%) Primitive dilatative cardiomyopathy, n (%) Valvular cardiomyopathy, n (%) Non-compaction, n (%) 14 (56) 8 (32) 2 (8) 1 (4)
AF, n (%) 15 (60)
LVEF (%), median [IQR] 27.0 [25.0–35.0]
Immunosuppressed state, n (%) AIDS, n (%) Immunosuppressive medication, n (%) 13 (52) 2 (8) 11 (44)
Active malignancy, n (%) 5 (20)
Type of Implant First ICD implant, n (%) Generator substitution, n (%) Conversion from TV device, n (%) Presence of abandoned leads, n (%) 12 (48) 3 (12) 10 (40) 1 (4)
Patients on OAC, n (%) 15 (60)
Previous device related infections, n (%) Precocious re-intervention, n (%) 12 (48) 3 (12)